Working Peter K

Avg. Two Year Performance

(22%) Avg. Purchase Return
(11%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return20%24%14%20%(22%)
Purchase Success Rate1 of 11 of 11 of 11 of 10 of 1
Average Sale Return----------
Sale Success Rate----------

Cell Genesys, Inc.

Drugs » Biotechnology

SVP R&D:

Holdings: 17.96K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--